Introduction
Members of the genus Acinetobacter are aerobic, non-fermenting Gram-negative bacilli, responsible for a wide spectrum of infections in immunocompromised hosts.
The Acinetobacter baumannii complex has emerged as some of the most important opportunistic pathogens within the hospital environment, being able to colonize and produce infections in most immunocompromised patients, especially from intensive care units 1 and/or in the context of serious underlying disease. Antimicrobial treatment of such severe infections is complicated by a widespread multidrug resistance pattern.
Different mechanisms of β-lactam resistance have been reported and identified in A. baumannii: β-lactamase production, 2 penicillinbinding protein alterations 3, 4 and reduced penetration across the outer membrane. 5 Nevertheless, β-lactamase production is one of the main mechanisms of resistance to β-lactams in Acinetobacter spp. Such β-lactamases can be plasmid-mediated enzymes like TEM-1 or CARB-5 penicillinases, 6, 7 integron-located class D oxacillinases, [8] [9] [10] class B metalloenzymes 11, 12 or chromosomally encoded cephalosporinases (AmpC) belonging to class C β-lactamases. 13, 14 The AmpC cephalosporinase was recently sequenced from a multi-resistant A. baumannii clinical strain (Ab RYC 52763/97) isolated during an outbreak in Spain. 14 This constitutively expressed enzyme does not share strong similarity with Enterobacteriaceae AmpC cephalosporinases. 15 As of yet there is no information about the regulation of A. baumannii AmpC expression. In this study, we examined the different β-lactam-resistance patterns encountered in 42 A. baumannii clinical strains and related this to AmpC expression. In order to investigate the changes in AmpC expression noted, we compared the genetic environment of the ampC gene in different strains showing different levels of β-lactam resistance.
Materials and methods

Bacterial strains
From January to December 2001, 42 strains of A. baumannii were isolated from 42 patients from different units at Nantes University Hospital. Identifications were performed with the Vitek2 system with an identification card for Gram-negative bacilli (ID-GNB) (bioMérieux, Marcy l'Étoile, France) and confirmed by overnight growth on Trypticase soy agar (bioMérieux) at 44°C.
Pulsed-field gel electrophoresis (PFGE)
DNA isolation from A. baumannii and PFGE were performed as previously described with some modifications 16 with a SmaI restriction. NCTC 8523 was used as DNA size marker. The interpretation of the banding pattern was performed according to Tenover et al. 16 
Susceptibility tests and MIC determination
Susceptibility to β-lactams was determined using the disc diffusion method (Bio-Rad, Marnes la Coquette, France) on Mueller-Hinton (MH) agar (Difco Laboratories, Detroit, MI, USA), according to the recommendations of the Comité de l'Antibiogramme de la Société Française de Microbiologie. 17 MICs were determined in the presence or absence of 500 mg/L of cloxacillin by serial two-fold dilution tests in MH agar. Inocula of 10 4 cfu/spot from an 18 h culture in MH broth were applied with a Steers multipleinoculum replicator.
A. baumannii ATCC 19606 was used as a control strain.
β-Lactamase extraction and isoelectric focusing
After 18 h of culture in Trypticase soy broth (bioMérieux), bacterial pellets were obtained by 20 min centrifugation at 10 000g. After washing and resuspension in distilled water, bacterial pellets were sonicated in a Branson Sonifier 250 to disrupt bacterial cell walls (intermittent exposure of 5× 30 s). After centrifugation, the supernatant contained the β-lactamase crude extract. Isoelectric focusing was performed according to the method of Matthew et al., 18 using an 8% acrylamide/bisacrylamide gel containing ampholines (pH 3.5-9.5). An iodine-starch agar gel, containing either benzylpenicillin or cloxacillin, was used to visualize the β-lactamase bands.
Detection of metallo-β-lactamase-producing strains
Metallo-β-lactamase production was detected by imipenem-EDTA and ceftazidime-EDTA double-disc synergy test. Clinical strains were inoculated on MH agar plates. Two 10 µg imipenem discs and two 30 µg ceftazidime discs (Bio-Rad) were placed on each plate, and 5 µL of a 0.5 M pH 8.0 EDTA solution were added onto one of each antibiotic disc. The inhibition zones were compared after 18 h of incubation at 37°C; metallo-β-lactamase production leads to a 6-12 mm diameter increase in the presence of EDTA. 19, 20 Detection of ampC by PCR annealing at 57°C and 60 s extension at 72°C, followed by a final extension step of 10 min at 72°C. The PCR products were detected on a 1.5% agarose gel.
Determination of the ampC genetic environment by inverse-PCR
Genomic DNA extraction was performed using QIAmp DNA MiniKit (Qiagen, Courtaboeuf, France) and DNA was digested with HindIII endonuclease for 3 h at 37°C. After heat inactivation of the enzyme, a ligation was performed using T 4 DNA ligase in a final volume of 10 µL.
After overnight incubation at 4°C, 10 µL of the ligation product was added to a PCR mixture containing two inverse primers (INV5 and INV6, opposite sense from ACI5 and ACI6). The PCR was performed as previously described, apart from an extension time increased to 2 min. A band of ∼1300 bp was obtained and sequenced in one strand using INV5 as a primer.
Amplification and sequencing of ampC 5′ non-coding sequence
After inverse-PCR and sequencing the 5′ non-coding region of susceptible strains, a new primer, ACI10 (5′-GCTGAACGCGATAAACTTC-3′), located upstream from the ampC gene was synthesized, and used with a primer located inside the ampC gene ACI2 (5′-TAGTACTGCTATT-TACGGCT-3′) corresponding to nucleotides 327-347 of the ampC gene. PCR was carried out as previously described.
Detection of integrons by integrase-PCR
Screening for the presence of class 1 integrons for each strain was realized as previously described with integrase-specific primers. 21 
RT-PCR analysis for ampC mRNA detection
Total mRNA was extracted from three A. baumannii strains representing each group (isolates 1, 2 and 3) using the Qiagen RNeasy Protect Bacteria Mini Kits (Qiagen). Five microlitres of DNase-treated RNA was reverse-transcripted in a final volume of 25 µL containing 50 mM of Tris-HCl pH 8.3, 75 mM KCl, 3 mM MgCl 2 , 10 mM DTT, 400 µM of each nucleotide, 2 µM of the reverse primer (ACI6 and 16S2) and 200 U of M-MLV reverse transcriptase (Promega). The reaction mixture was incubated for 1 h at 42°C, followed by a 5 min incubation at 95°C. Ten microlitres of the cDNA was used for amplification of specific ampC mRNA, using the primers for ampC (ACI5/ACI6) and 10 µL for the 16S rRNA (16S1 5′-GGAGGAAGGTGGGGATGACG-3′ and 16S2 5′-ATGGTGTGACGGGCGGTGTG-3′) 22 under the same conditions: 5 min initial denaturation at 94°C, followed by 35 cycles of 30 s denaturation at 94°C, 30 s annealing at 55°C and 1 min extension at 72°C, and a final extension step of 7 min at 72°C. Both PCR products were detected on a 1.5% agarose gel. Each RT-PCR was performed in triplicate. were also resistant to the carbapenem, imipenem (MIC ≥ 32 mg/L), and the imipenem MICs were not modified in the presence of cloxacillin. All the group I and II strains were susceptible to imipenem, and its MIC decreased (twice for group I strains and three-to four-fold in group II strains) in the presence of cloxacillin. PFGE molecular typing of the 42 isolates showed that all group I and II isolates represent different strains. However, 75% of group III isolates were collected from a burns intensive care unit and presented a high degree of similarity (>90%) (data not shown).
Results
β-Lactam resistance and β-lactamase expression by clinical A. baumannii isolates
Isoelectric focusing was performed on the crude β-lactamase extracts of all 42 isolates. For 12 strains (all in group I), no β-lactamase could be detected, probably because β-lactamase expression was below the sensitivity of the method. For 30 strains (71%), including all the group II and III strains, a basic β-lactamase band, most probably corresponding to the AmpC cephalosporinase (pI > 8), was detected. In all cases, the AmpC band intensity was higher for strains from groups II and III than from group I. Several strains showed an additional β-lactamase band with a pI of 5.4. These strains were also characterized by their resistance to ticarcillin, decreased by clavulanate, so the pI 5.4 band most probably represents a TEM-type β-lactamase. For 10 group III strains having an imipenem MIC ≥32 mg/L, a pI 6.3 band was also visible after revelation with an iodinestarch agar gel containing cloxacillin instead of benzylpenicillin. Tests for the presence of a metallo-β-lactamase in these strains was negative using imipenem-EDTA and ceftazidime-EDTA screening discs.
ampC gene upstream sequence and AmpC expression in clinical A. baumannii isolates
PCR tests for the ampC gene were positive for all 42 strains. However, using forward and reverse primers (ACI1 and ACI2) located in the 5′ non-coding sequence and ampC gene, respectively, previously published by Bou & Martinez-Beltran, 14 group I (ceftazidime susceptible) strains did not give any PCR amplification product, as shown in Table 2 . By inverse PCR, we determined the immediate 5′ upstream region of the ampC genes of these group I strains. The sequence obtained is very different from the ampC upstream regions of group II and III (ceftazidime resistant) isolates, as shown in Figure1. A PCR was then performed with template DNA from all the strains using a forward primer anchored in the ampC upstream sequence from group I isolates (ACI10) and the ampC-targeted reverse primer used previously (ACI2). Following this reaction, group I strains yielded an amplicon of 356 bp, but group II and III isolates gave an ∼1500 bp amplicon. These results suggested an insertion upstream from the ampC gene in groups II and III isolates. The 1500 bp product was sequenced on both strands. Compared with the group I isolates, an insertion sequence of ∼1200 bp, with characteristic direct repeats of 9 bp (5′-GAGCTAATC-3′) and inverted repeats of 11 bp (5′-CTCTGTACACG-3′), was present in the 5′ noncoding region of all group II and III strains. An alignment of this sequence with the EMBL database (http://www.ncbi.nlm.nih.gov/ BLAST/) revealed 100% identity with an upstream sequence of the phaB AC gene in A. baumannii, encoding an acetoacetyl-CoA reductase. 23, 24 This sequence was also previously detected upstream of the ARI-1 gene, encoding OXA-23, an extended-spectrum class D β-lactamase, in A. baumannii strains. 25 RT-PCR analysis was conducted in order to estimate ampC transcript levels in the three different groups of strains. While a control reaction (measuring 16S rRNA levels) gave a similar strong signal for the three groups of strains, a large difference was obtained for the ampC-specific transcript (Figure 2) . ampC mRNA is considerably more abundant in both group II and III strains, which have the ampC upstream insertion, than in group I strains, which do not.
The presence of integrase genes was confirmed by PCR in some of the strains, but there is no clear correlation with the presence of the ampC upstream insertion sequence (Table 2) . 
Discussion
In Escherichia coli, the main mechanism of overproduction of the constitutive AmpC enzyme is the acquisition of point mutations in the ampC promoter and attenuator regions. [26] [27] [28] [29] In A. baumannii, it appears that the presence of an ∼1200 bp sequence upstream of ampC causes overexpression of AmpC. This 1200 bp sequence presents structural elements characteristic of an insertion sequence (IS): creation of direct repeats of 9 bp in the target sequence and presence of inverted repeats of 11 bp at each end of the inserted fragment. 30 RT-PCR analysis confirms the difference in the level of expression of the AmpC cephalosporinase. Furthermore, the RT-PCR results were in accordance with the ceftazidime MICs. Thus, the presence of the insertion sequence in both groups II and III probably increased the resistance. Accordingly, our experimental data suggest that overexpression of the ampC gene could be mediated by this IS, by providing a strong promoter upstream from the start codon ATG of the gene.
In E. coli, the crucial step of initiation of mRNA synthesis is strongly influenced by the sequence of two hexamers, the -35 and -10 boxes. 31 At these sites, consensus sequences have been defined for E. coli, respectively TTGACA and TATAAT, optimally separated by 17 bp. The closer sequences are to the consensus sequences, the stronger the promoter. The first two bases of the hexamers are known to be the best conserved ones among the various promoters sequenced. 31 No data are available about A. baumannii promoter consensus sequences. However, putative -35 and -10 boxes (TTGTTC and TATGAT) separated by 17 bp could be detected in the mobile element about 100 bp upstream of the start codon in the A. baumannii ampC gene. They differ from the E. coli consensus sequences by three bases and one base, respectively, the first bases being conserved.
Gene activation or inactivation by transposition of an IS element is a well-known phenomenon. Jaurin & Normark 32 described AmpC overproducing E. coli laboratory mutants with an IS2 insertion sequence located in the promoter, leading to a 20-fold increase in promoter strength. On the other hand, in E. coli, enhanced efflux expression has been associated with insertion of IS186 into the AcrAB repressor gene acrR, inducing reduced susceptibility to fluoroquinolones. 33 Our data confirm the role of mobile elements in modifying transcription rates of bacterial resistance genes.
Alignment with databases revealed 100% identity between the ampC upstream IS and the phaB AC upstream sequence, a mobile element previously found in the A. baumannii genome. Most interestingly, this same IS has been found upstream of the class D β-lactamase ARI-1. 25 To our knowledge, it is the first time that the same mobile element could be found upstream of both a class D oxacillinase gene usually located on integrons 34,35 and a class C gene like ampC. However, the same insertion sequence has been very recently detected upstream of the aac(3)IIa gene, encoding an aminoglycoside modifying enzyme. 36 This mobile element seems to be widespread, and It has also been shown recently that Oligella urethralis has integrated the A. baumannii ampC gene into its chromosome. The ampC gene in question carries the same upstream sequence as our group I strain. 37 The distribution of the different resistance patterns in our study was very similar to that described by Danes et al., 2 with nearly half of the strains being susceptible or moderately resistant to ceftazidime, and 33.4% showing a decreased susceptibility or resistance to imipenem. This resistance was not corrected by cloxacillin, so a mechanism other than AmpC β-lactamase overproduction must be involved. Carbapenem resistance in A. baumannii has been associated with modifications in outer membrane proteins 5 or penicillin-binding proteins, 3, 4 and production of different β-lactamases. 2 Class B enzymes have been described in A. baumannii, 11, 12 but the search for a metallo-enzyme was negative using an imipenem-EDTA or ceftazidime-EDTA test. 19, 20 Furthermore, numerous studies have shown that imipenem resistance in A. baumannii was mostly linked to the production of a class D extended-spectrum oxacillinase. [8] [9] [10] These enzymes belong to two different clusters (OXA23/27 and OXA 24/25/26/40) and the genes encoding OXA-type β-lactamases are often located on class 1 integrons. 38 The integrase gene was detected by PCR in all the imipenem resistant strains of our study, but no oxacillinase gene could be detected with primers belonging to both clusters. Studies are in progress to understand the mechanism(s) underlying decreased susceptibility to imipenem of these strains. 
